Literature DB >> 10987816

Functional characterization of a cis-acting DNA antisilencer region that modulates myelin proteolipid protein gene expression.

A Dobretsova1, N A Kokorina, P A Wight.   

Abstract

Regulation of myelin proteolipid protein (PLP:) gene expression is tightly controlled, both spatially and temporally. Previously, we have shown with transgenic mice that a PLP:-lacZ fusion gene (which includes the entire sequence for PLP: intron 1 DNA) is regulated in a similar manner to endogenous PLP: gene expression. Furthermore, by deletion-transfection analyses using assorted PLP:-lacZ constructs with partial deletion of PLP: intron 1 sequences, we have shown that the first intron possesses an antisilencer region that is capable of over-coming repression mediated by two distinct regions located elsewhere within intron 1 DNA. Here, we report the ability of various fragments encompassing the antisilencer region to restore beta-galactosidase activity when inserted into PLP:-lacZ constructs, which originally exhibited low levels of beta-galactosidase activity. Additional constructs were generated to test the effects of these antisilencer-containing fragments in constructs that are missing either one or both of the negative regulatory regions that are overridden during antisilencing. Transfection analyses, in conjunction with protein-DNA binding assays, suggest that several nuclear factors are necessary for derepression of PLP: gene activity in an oligodendroglial cell line. Moreover, either the "core" or complete antisilencing region can act in an additive or synergistic fashion when multiple copies are inserted into the Plp-lacZ constructs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987816     DOI: 10.1046/j.1471-4159.2000.0751368.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Expression of a myelin proteolipid protein (Plp)-lacZ transgene is reduced in both the CNS and PNS of Plp(jp) mice.

Authors:  Patricia A Wight; Cynthia S Duchala; H Elizabeth Shick; Tatyana I Gudz; Wendy B Macklin
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

2.  Expression of myelin genes: comparative analysis of Oli-neu and N20.1 oligodendroglial cell lines.

Authors:  Glauber B Pereira; Anna Dobretsova; Hamdan Hamdan; Patricia A Wight
Journal:  J Neurosci Res       Date:  2011-04-06       Impact factor: 4.164

3.  Leydig cells express the myelin proteolipid protein gene and incorporate a new alternatively spliced exon.

Authors:  Shenyang Li; Brian T Greuel; Fanxue Meng; Glauber B Pereira; Adria Pitts; Anna Dobretsova; Patricia A Wight
Journal:  Gene       Date:  2009-02-13       Impact factor: 3.688

4.  Targeted deletion of the antisilencer/enhancer (ASE) element from intron 1 of the myelin proteolipid protein gene (Plp1) in mouse reveals that the element is dispensable for Plp1 expression in brain during development and remyelination.

Authors:  Glauber B Pereira; Fanxue Meng; Neriman T Kockara; Baoli Yang; Patricia A Wight
Journal:  J Neurochem       Date:  2012-12-21       Impact factor: 5.372

5.  The wmN1 Enhancer Region of the Mouse Myelin Proteolipid Protein Gene (mPlp1) is Indispensable for Expression of an mPlp1-lacZ Transgene in Both the CNS and PNS.

Authors:  Pankaj Patyal; Neriman T Kockara; Patricia A Wight
Journal:  Neurochem Res       Date:  2019-11-28       Impact factor: 3.996

6.  Proteomic analysis of nuclear factors binding to an intronic enhancer in the myelin proteolipid protein gene.

Authors:  Anna Dobretsova; Jennifer W Johnson; Richard C Jones; Ricky D Edmondson; Patricia A Wight
Journal:  J Neurochem       Date:  2008-02-07       Impact factor: 5.372

7.  YY1 negatively regulates mouse myelin proteolipid protein (Plp1) gene expression in oligodendroglial cells.

Authors:  Olga E Zolova; Patricia A Wight
Journal:  ASN Neuro       Date:  2011-11-03       Impact factor: 4.146

8.  Control of human PLP1 expression through transcriptional regulatory elements and alternatively spliced exons in intron 1.

Authors:  Hamdan Hamdan; Neriman T Kockara; Lee Ann Jolly; Shirley Haun; Patricia A Wight
Journal:  ASN Neuro       Date:  2015-02-18       Impact factor: 4.146

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.